{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:31:25Z","timestamp":1769243485984,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cyto.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T06:10:06Z","timestamp":1503036606000},"page":"145-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["IL-1 family cytokines and receptors in IgG4-related disease"],"prefix":"10.1016","volume":"102","author":[{"given":"Riccardo","family":"Capecchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Italiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Puxeddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Pratesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Tavoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Boraschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2017.08.001_b0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cyto.2017.08.001_b0010","doi-asserted-by":"crossref","unstructured":"D. Inoue, K. Yoshida, N. Yoneda, K. et al., IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94 (15) (2015) e680.","DOI":"10.1097\/MD.0000000000000680"},{"key":"10.1016\/j.cyto.2017.08.001_b0015","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2017.08.001_b0020","doi-asserted-by":"crossref","unstructured":"A. Grados, M. Ebbo, T cell polarization toward Th2\/TFh2 and Th17\/TFh17 in Patients with IgG4-related disease. Frontiers Immunol., 2017 (in press).","DOI":"10.3389\/fimmu.2017.00235"},{"key":"10.1016\/j.cyto.2017.08.001_b0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2017.08.001_b0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","article-title":"Lesional CD4+ IFN-\u03b3+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis","volume":"76","author":"Maehara","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2017.08.001_b0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2017.08.001_b0040","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.humpath.2015.08.002","article-title":"IL-18 is highly expressed in inflammatory infiltrates of submandibular glands in patients with immunoglobulin G4-related disease","volume":"46","author":"Komori","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cyto.2017.08.001_b0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1359-6101(00)00015-0","article-title":"Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu","volume":"12","author":"Nakanishi","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2017.08.001_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-independent regulation of IL-1-family cytokines","volume":"33","author":"Netea","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2017.08.001_b0055","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1189\/jlb.3RI1214-595R","article-title":"New dog and new tricks: evolving roles for IL-33 in type 2 immunity","volume":"97","author":"Lott","year":"2015","journal-title":"J. Leukoc Biol."},{"key":"10.1016\/j.cyto.2017.08.001_b0060","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1073\/pnas.1601914113","article-title":"Alternative splicing of interleukin-33 and type 2 inflammation in asthma","volume":"113","author":"Gordon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2017.08.001_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)","volume":"1","author":"Umehara","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cyto.2017.08.001_b0070","doi-asserted-by":"crossref","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD Responder Index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol."},{"key":"10.1016\/j.cyto.2017.08.001_b0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cyto.2017.08.001_b0080","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.97.3.1190","article-title":"Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18","volume":"97","author":"Kim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2017.08.001_b0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.2001.0914","article-title":"A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18","volume":"14","author":"Novick","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.08.001_b0090","first-page":"264","article-title":"Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus","volume":"21","author":"Migliorini","year":"2010","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cyto.2017.08.001_b0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"Boraschi","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.cyto.2017.08.001_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1189\/jlb.3RU0115-012R","article-title":"The potential role of IL-33\/ST2 signaling in fibrotic diseases","volume":"98","author":"Gao","year":"2015","journal-title":"J. Leukoc Biol."},{"key":"10.1016\/j.cyto.2017.08.001_b0105","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2017.08.001_b0110","doi-asserted-by":"crossref","first-page":"e79176","DOI":"10.1371\/journal.pone.0079176","article-title":"A role for soluble ST2 in vascular remodeling associated with obesity in rats","volume":"8","author":"Mart\u00ednez-Mart\u00ednez","year":"2013","journal-title":"PLoS One"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:33Z","timestamp":1760907093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617302272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":22,"alternative-id":["S1043466617302272"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.08.001","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1 family cytokines and receptors in IgG4-related disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}